Tag Archives: congenital hyperinsulinism

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests of its AI-powered technology. The cash tops off a Series B round of funding announced last year. The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: […]

Posted in Boston, Boston blog main, Boston top stories, Indiana blog main, National blog main, New York blog main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests